JP2021526513A5 - - Google Patents

Info

Publication number
JP2021526513A5
JP2021526513A5 JP2020564572A JP2020564572A JP2021526513A5 JP 2021526513 A5 JP2021526513 A5 JP 2021526513A5 JP 2020564572 A JP2020564572 A JP 2020564572A JP 2020564572 A JP2020564572 A JP 2020564572A JP 2021526513 A5 JP2021526513 A5 JP 2021526513A5
Authority
JP
Japan
Prior art keywords
tipifanib
mixture
racemic
iii
product mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020564572A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526513A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/032765 external-priority patent/WO2019222565A1/en
Publication of JP2021526513A publication Critical patent/JP2021526513A/ja
Publication of JP2021526513A5 publication Critical patent/JP2021526513A5/ja
Withdrawn legal-status Critical Current

Links

JP2020564572A 2018-05-18 2019-05-17 ティピファニブの合成 Withdrawn JP2021526513A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862673693P 2018-05-18 2018-05-18
US62/673,693 2018-05-18
PCT/US2019/032765 WO2019222565A1 (en) 2018-05-18 2019-05-17 Synthesis of tipifarnib

Publications (2)

Publication Number Publication Date
JP2021526513A JP2021526513A (ja) 2021-10-07
JP2021526513A5 true JP2021526513A5 (https=) 2022-05-24

Family

ID=66770583

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020564572A Withdrawn JP2021526513A (ja) 2018-05-18 2019-05-17 ティピファニブの合成

Country Status (13)

Country Link
US (1) US11542244B2 (https=)
EP (1) EP3793966A1 (https=)
JP (1) JP2021526513A (https=)
KR (1) KR20210039987A (https=)
CN (1) CN112424149B (https=)
AU (1) AU2019270163A1 (https=)
BR (1) BR112020023559A2 (https=)
CA (1) CA3100706A1 (https=)
EA (1) EA202092787A1 (https=)
MX (1) MX2020012305A (https=)
PH (1) PH12020551956A1 (https=)
SG (1) SG11202011378WA (https=)
WO (1) WO2019222565A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102839264B1 (ko) 2023-03-07 2025-07-29 단국대학교 천안캠퍼스 산학협력단 티피파르닙을 유효성분으로 포함하는 근감소증 예방 또는 치료용 약학 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2200490C (en) * 1994-09-23 2007-01-09 Chiroscience Limited Racemisation and asymmetric transformation processes used in the manufacture of levobupivacaine and analogues thereof
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
SK283335B6 (sk) 1995-12-08 2003-06-03 Janssen Pharmaceutica N. V. (Imidazol-5-yl)metyl-2-chinolinónové deriváty, spôsob a medziprodukty na ich prípravu, ich použitie a farmaceutické kompozície na ich báze
BRPI0208075B8 (pt) * 2001-03-12 2021-05-25 Janssen Pharmaceutica Nv processo para a preparação de compostos de imidazol
EP1758885B1 (en) * 2004-05-03 2008-06-18 Janssen Pharmaceutica N.V. Diastereoselective addition of lithiated n-methylimidazole on sulfinimines
JP4917022B2 (ja) * 2004-05-03 2012-04-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 6−ブロモ−4−(3−クロロフェニル)−2−メトキシ−キノリンを用いるジアステレオ選択的合成方法
CA2563807C (en) * 2004-05-03 2012-11-20 Janssen Pharmaceutica N.V. Diastereoselective synthesis process for the preparation of imidazole compounds
JP6640220B2 (ja) * 2014-11-21 2020-02-05 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung プラジカンテルの製造方法
CN104876856B (zh) 2015-05-05 2017-11-21 河北凯力昂生物科技有限公司 一种拆分法制备(r)‑(+)‑3‑氨基哌啶二盐酸盐的方法

Similar Documents

Publication Publication Date Title
JP2022031717A5 (https=)
JP2017524742A5 (https=)
JP2021526513A5 (https=)
JP2021504418A5 (https=)
HRP20191172T1 (hr) Proces za proizvodnju aminokiselina iz prekursora dobivenih anaerobnom fermentacijom iz fermentabilne biomase
WO2014034957A1 (ja) (r)-1,1,3-トリメチル-4-アミノインダンの製造方法
JP5999600B2 (ja) 光学活性テトラヒドロフラン−2−カルボン酸の製造方法
Szeleczky et al. The effect of SDE on the separation of diastereomeric salts: a case study for the resolution of mandelic acid derivatives with Pregabalin
TWI428311B (zh) 使用酒石酸分離三衍生物鏡像異構物
JP2013531021A (ja) フェブキソスタットの結晶形iiを調製するための方法
EP2586769B1 (en) Method for producing (1r, 2s)-1-amino-2-vinyl cyclopropane carboxylic acid ester that has improved optical purity
CN101875603B (zh) 截短侧耳素类抗生素合成中间体姆替林的制备方法
CN112939911A (zh) 一种制备左旋Corey内酯关键中间体的手性拆分工艺
CN101735070A (zh) 一种r-(+)-1-(1-萘)乙胺的拆分方法
JP2016525094A5 (https=)
JP2010037206A (ja) 光学活性なo−メチルセリンまたはその塩の製造法
WO2013058241A1 (ja) (r)-2-アミノ-2-エチルヘキサノールの製造法
CN105061219A (zh) 一种制备s-1-氨基茚满的方法
JP5714213B2 (ja) 2,6−trans−ジメチルモルホリンのラセミ分離
EP2358665B1 (fr) Procede de preparation de l'hemifumarate d'eplivanserine
JP2004143170A (ja) エナンチオ濃縮された3−アミノペンタニトリルまたはその塩を得るための方法
CA1072120A (en) Nopinylamines
CN100534989C (zh) (rs)-苯并二噁烷-2-甲酸的拆分方法
JP6255343B2 (ja) D−アロイソロイシンの製造方法
JP5510040B2 (ja) 光学活性(r)−1−(4−フルオロフェニル)エチルアミンを得る光学分割